Table 1.
Patient and angiographic characteristics.
| Patient No. | Age(yrs) | Sex(M/F) | Interval(months) | Ischaemia | Medication | Minimaldiameter baseline | Length of bridge | Spasm Y/N | CFR | Dobu(Y/N) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | B | C ACE | N | S | ||||||||||
| 1 | 39 | M | 18 | 1 | + | + | -- | + | + | 0.82 | 29.24 | Y | 2.6 | N |
| 2 | 49 | F | 16 | 1 | + | - | -+ | - | + | 1.06 | 19.63 | N | 3.1 | Y |
| 3 | 55 | M | 2 | 1 | + | + | -- | - | + | 0.92 | 28.69 | N | 4.5 | Y |
| 4 | 55 | M | 12 | 2 | + | + | -- | - | + | 0.77 | 34.79 | N | 3.3 | N |
| 5 | 60 | M | 6 | 2 | + | + | -- | + | + | 0.93 | 27.55 | N | 3.7 | Y |
| 6 | 55 | M | 9 | 2 | - | - | + + | + | + | 1.08 | 18.28 | N | 2.9 | Y |
| 7 | 33 | M | 120 | 2 | - | - | + - | - | - | 1.33 | 14.06 | N | Y | |
| 8 | 37 | M | 0 | 2 | + | + | + + | - | + | 1.03 | 8.32 | N | 3.7 | Y |
| 9 | 66 | M | ? | 1 | + | + | + - | + | + | 1.25 | 33.51 | N | 3.5 | Y |
| 10 | 38 | M | ? | 2 | + | + | + - | - | - | N | 2.8 | Y | ||
| 11 | 44 | F | 15 | 3 | - | - | -- | - | + | 1.34 | 17.13 | Y | N | |
| 12 | 54 | M | 0 | 2 | - | - | -- | - | - | 1.37 | 42.25 | N | Y |
Dobu=dobutamine, CFR=coronary flow velocity reserve, interval=interval between presentation of symptoms and test. Ischaemia: 1=positive exercise test, 2=positive myocardial scintigraphy, 3= ischaemia on rest electrocardiogram. Medication: A = acetylsalicylic acid, B=β-blocker, C=calcium receptor antagonist, ACE=ACE inhibitor, N=long-acting nitrate, S=statin. Spasm: in patient no. 1 diastolic diameter decreased from 1.11 mm to 0.3 mm and in patient no. 11 an occlusive spasm during the lowest acetylcholine dose was observed.